Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03617692 · ClinicalTrials.gov registry record
Cannabis Use in Cancer Patients
A clinical trial of Solid Tumor, Adult, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 27
- Enrollment target
- 2
- Study locations
NCT03617692 is a study of Solid Tumor, Adult that has completed, run by University of Colorado, Denver. The registered enrollment target is 27 participants, below the 190-participant average among 72 other Solid Tumor, Adult trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03617692, a study of Solid Tumor, Adult, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to determine the feasibility of a human observational study of orally administered cannabis use among cancer patients.
Conditions Studied
Study Locations (2)
Colorado
- University of Colorado Hospital - Aurora
- University of Colorado Boulder - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-12-04 |
| Est. Completion | 2022-12-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03617692
The ClinicalTrials.gov registry entry for NCT03617692 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 72 other Solid Tumor, Adult trials with a reported enrollment target (86% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Solid Tumor, Adult appearing as the primary indexed condition, and to 0 interventions.
NCT03617692 reports 2 study locations spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT03617692 about?
NCT03617692 is a clinical study titled "Cannabis Use in Cancer Patients". The goal of this study is to determine the feasibility of a human observational study of orally administered cannabis use among cancer patients.
What is the current status of trial NCT03617692?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2018-12-04. Estimated completion is 2022-12-12.
What conditions does trial NCT03617692 study?
This clinical trial studies the following conditions: Solid Tumor, Adult.
Who is sponsoring clinical trial NCT03617692?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03617692 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumor, Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
RECRUITING
-
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
RECRUITING · Phase 2
-
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
RECRUITING · NA
-
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RECRUITING · Phase 1
-
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
RECRUITING · Phase 1
-
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.